Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Common Equity (2019 - 2025)

Pulmonx (LUNG) has disclosed Common Equity for 7 consecutive years, with $69.1 million as the latest value for Q2 2025.

  • Quarterly Common Equity fell 31.72% to $69.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $69.1 million through Jun 2025, down 31.72% year-over-year, with the annual reading at $85.8 million for FY2024, 27.47% down from the prior year.
  • Common Equity for Q2 2025 was $69.1 million at Pulmonx, down from $77.7 million in the prior quarter.
  • The five-year high for Common Equity was $216.1 million in Q1 2021, with the low at $69.1 million in Q2 2025.
  • Average Common Equity over 5 years is $145.8 million, with a median of $149.0 million recorded in 2022.
  • The sharpest move saw Common Equity soared 211.39% in 2021, then crashed 31.72% in 2025.
  • Over 5 years, Common Equity stood at $193.2 million in 2021, then dropped by 20.3% to $154.0 million in 2022, then fell by 23.18% to $118.3 million in 2023, then decreased by 27.47% to $85.8 million in 2024, then decreased by 19.48% to $69.1 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $69.1 million, $77.7 million, and $85.8 million for Q2 2025, Q1 2025, and Q4 2024 respectively.